Brief: Nanoform, PlusVitech Partner To Repurpose Aprepitant As Treatment For Lung Cancer

Nanoform Finland Oyj

09/04/2024 07:05

April 9 (Reuters) - Nanoform Finland Oyj  NANOFH.HE :
    * NANOFORM AND PLUSVITECH PARTNER TO REPURPOSE APREPITANT AS
A
TREATMENT FOR LUNG CANCER
    * PARTNERSHIP IS EXPECTED TO INCLUDE API SUPPLY FOR
LATE-STAGE
CLINICAL PROGRAMS AND EVENTUAL PRODUCT LAUNCH

Source text for Eikon:  ID:nWkr4NfmB8 
Further company coverage:  NANOFH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))